Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3332/ecancer.2020.1060 http://scihub22266oqcxt.onion/10.3332/ecancer.2020.1060 32582375!7302891!32582375     free     free     free       Ecancermedicalscience 2020 ; 14 (?): 1060 Nephropedia Template TP {{tp|p=32582375|t=2020. Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries |pdf=|usr=}}{{32582375}} gab.com Text Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries JO: Ecancermedicalscience http://www.kidney.de/pget.php?&tw=1&pmid=32582375 #FOAvip During the COVID-19 pandemic, health services worldwide are going through important adaptations to assist patients infected with COVID-19, at the same time as continuing to provide assistance to other potentially life-threatening diseases. Although patients with cancer may be at increased risk for severe events related to COVID-19 infection, their oncologic treatments frequently cannot be delayed for long periods without jeopardising oncologic outcomes. Considering this, a careful consideration for treatment management of different malignancies is required. Cervical cancer is concentrated mainly in low-middle income countries (LMICs), which face particular challenges during the COVID-19 pandemic due to the scarcity of health resources in many places. Although cervical cancer is the fourth cause of cancer death among women, it receives little attention from international Oncology societies and scientific research studies. In this review paper, we discuss the cervical cancer landscape and provide specialists recommendations for its management during the COVID-19 pandemic, particularly focused on LMICs' reality. Twit Text FOAVip Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries ????Ecancermedicalscience http://www.kidney.de/pget.php?&tw=1&pmid=32582375 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32582375 #FOAvip English Wikipedia <ref>{{Cite pmid|32582375}}</ref> Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries #MMPMID32582375 Del Pilar Estevez-Diz M; Bonadio RC; Miranda VC; Carvalho JP Ecancermedicalscience 2020[]; 14 (?): 1060 PMID32582375show ga During the COVID-19 pandemic, health services worldwide are going through important adaptations to assist patients infected with COVID-19, at the same time as continuing to provide assistance to other potentially life-threatening diseases. Although patients with cancer may be at increased risk for severe events related to COVID-19 infection, their oncologic treatments frequently cannot be delayed for long periods without jeopardising oncologic outcomes. Considering this, a careful consideration for treatment management of different malignancies is required. Cervical cancer is concentrated mainly in low-middle income countries (LMICs), which face particular challenges during the COVID-19 pandemic due to the scarcity of health resources in many places. Although cervical cancer is the fourth cause of cancer death among women, it receives little attention from international Oncology societies and scientific research studies. In this review paper, we discuss the cervical cancer landscape and provide specialists recommendations for its management during the COVID-19 pandemic, particularly focused on LMICs' reality. ?Management of cervical cancer patients during the COVID-19 pandemic: a(epmc).pdf DeepDyve Pubget Overpricing